PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

NCT02905942 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: PEG-rhG-CSF
DRUG: rhG-CSF

Sponsor

Peking University